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Abstract
The Quality of Life Scale (QOLS), created originally by American psychologist John Flanagan in the
1970's, has been adapted for use in chronic illness groups. This paper reviews the development and
psychometric testing of the QOLS. A descriptive review of the published literature was undertaken
and findings summarized in the frequently asked questions format. Reliability, content and construct
validity testing has been performed on the QOLS and a number of translations have been made.
The QOLS has low to moderate correlations with physical health status and disease measures.
However, content validity analysis indicates that the instrument measures domains that diverse
patient groups with chronic illness define as quality of life. The QOLS is a valid instrument for
measuring quality of life across patient groups and cultures and is conceptually distinct from health
status or other causal indicators of quality of life.
Why assess Quality of Life in chronic illness?
Quality of life (QOL) measures have become a vital and
often required part of health outcomes appraisal. For pop-
ulations with chronic disease, measurement of QOL pro-
vides a meaningful way to determine the impact of health
care when cure is not possible. Over the past 20 years,
hundreds of instruments have been developed that pur-
port to measure QOL [1]. With few exceptions, these
instruments measure what Fayers and colleagues [2,3]
have called causal indicators of QOL rather than QOL
itself. Health care professionals need to be clear about the
conceptual definition of QOL and not to confound it with
functional status, symptoms, disease processes, or treat-
ment side-effects [4–7]. Although the definition of QOL is
still evolving, Revicki and colleagues define QOL as "a
broad range of human experiences related to one's overall
well-being. It implies value based on subjective function-
ing in comparison with personal expectations and is
defined by subjective experiences, states and perceptions.
Quality of life, by its very natures, is idiosyncratic to the
individual, but intuitively meaningful and understanda-
ble to most people [[8], p. 888]." This definition denotes
a meaning for QOL that transcends health. The Quality of
Life Scale (QOLS) first developed by American psycholo-
gist, John Flanagan, [9,10] befits this definition of QOL.
What does the Quality of Life Scale (QOLS) 
measure?
The QOLS was originally a 15-item instrument that meas-
ured five conceptual domains of quality of life: material
and physical well-being, relationships with other people,
social, community and civic activities, personal
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descriptive research that queried persons with chronic ill-
ness on their perceptions of quality of life, the instrument
was expanded to include one more item: Independence,
the ability to do for yourself. Thus, the QOLS in its present
format contains 16 items. See Table 1 for the individual
items within each conceptual category in the original
Flanagan version of the scale.
How was the QOLS developed?
The original work on the QOLS was undertaken in the
United States in the mid-1970's. Using the critical inci-
dent technique, nearly 3,000 people of various ages, eth-
nic groups, and backgrounds from all parts of the United
States were asked to contribute experiences that were
important or satisfying to them. Substantial efforts were
made to include ethnic minorities, rural inhabitants, sen-
ior citizens, and low income groups. As Flanagan stated,
"The purpose of using the regional samples and diverse
groups was not to obtain accurate estimates of frequencies
but rather to insure that differing points of view and types
of experience were represented [[9], p. 138]."
With the possible exception of Cantril's ladder [11], no
other QOL instrument currently in general circulation has
been developed with such extensive attention to diversity
and individual perspective. The original QOLS contained
15 items representing 5 conceptual domains of QOL that
were empirically derived from the 6500 critical incidents
that Flanagan and his team collected.
In a second step, Flanagan used the instrument to survey
a total of 3,000 people, ages 30, 50, and 70, using 5-point
scales of "importance" and "needs met." The results of this
national survey revealed that most people of both genders
and all three ages felt that the items were important to
them. The only exceptions were in the areas of participat-
ing in local and national government and public affairs
(Item #8) which a majority of 30-year olds did not think
was important, and creative expression (Item #12), social-
izing (Item #13) and passive recreation (Item #14) which
less than a majority of men endorsed as important. Nev-
ertheless, a majority of all people of both genders and all
age groups was satisfied that their needs were being met in
all areas [10].
Item Scaling
The original work by Flanagan [9] used two five-point
scales of "importance" and "needs met." No reliability of
this scaling was reported at the time. Earlier work by
Andrews and Crandall [12] had suggested that a 7-point
scale anchored with the words "delighted" and "terrible"
was more sensitive and less negatively skewed than a 5-
point satisfaction scale for quality of life assessment,
probably because it allowed for a broader range of affec-
tive responses to QOL items. The seven responses were
"delighted" (7), "pleased" (6), "mostly satisfied" (5),
"mixed" (4), "mostly dissatisfied" (3), "unhappy" (2),
"terrible" (1). For all work undertaken to adapt the scale
for use in American chronic illness populations, the 7-
point delighted-terrible scale was used to measure satis-
faction with an item. The 5-point importance scale was
used only for determining content validity in the initial
chronic illness study [13].
How was the QOLS validated?
Flanagan did not report internal consistency reliability
(Cronbach's alpha) estimates in his instrument develop-
ment work. Estimates from the first study of 240 American
patients with chronic illness (diabetes, osteoarthritis,
Table 1: Flanagan Quality of Life Scale (QOLS) original conceptual categories and scale items.
Conceptual Category Scale Item
Material and Physical Well-being Material well-being and financial security
Health and personal safety
Relationships with other People Relations with parents, siblings, other relatives
Having and raising children
Relations with spouse or significant other
Relations with Friends
Social, Community, and Civic Activities Activities related to helping or encouraging others
Activities related to local and national government
Personal Development and Fulfillment Intellectual development
Personal understanding
Occupational role
Creativity and personal expression
Recreation Socializing
Passive and observational recreational activities
Active and participatory recreational activitiesPage 2 of 7
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that the 15-item QOLS satisfaction scale was internally
consistent (α = .82 to .92) and had high test-retest reliabil-
ity over 3-weeks in stable chronic illness groups (r = 0.78
to r = 0 .84) [13]. Other researchers have reported similar
reliability estimates for the 16-item scale [14–17].
The quality and quantity of descriptive work with large
numbers of Americans provided strong evidence for con-
tent validity of the QOLS during its early development.
However, Flanagan, himself, reasoned that some adapta-
tions for persons with chronic conditions or disabilities
might be needed and that different rating scales might
produce divergent results. In 1981 Professor Flanagan
gave the first author permission to adapt the scale for
patients with chronic illness. Over the intervening years
the QOLS has been called the "Adapted Quality of Life
Scale" or "Flanagan Quality of Life Scale." In this paper it
will be called simply the QOLS and always refer to the 16-
item scale as adapted by Burckhardt and colleagues for
persons with chronic illness.
When the 240 Americans with chronic illness were asked
open-ended questions about what the term "quality of
life" meant to them and what was important to their QOL,
they generated words and phrases that were very similar to
those used by the general population that Flanagan had
studied. The importance of material comforts and secu-
rity, health, relationships with both family and friends,
understanding of themselves, as well as the ability to
socialize, participate in activities and have satisfying work
experiences were all apparent in their descriptions. How-
ever, they also generated a list of phrases that could be
best described as "efforts to remain independent" using
words and phrases, such as "independence", "able to care
for myself", and "being physically active". This item was
added to the QOLS to make a 16-item scale: "Independ-
ence, ability to do for oneself" [13]. In addition, during
this process the wording of item #8 "activities related to
local and national government" was broadened to "partic-
ipating in organizations and public affairs." This reword-
ing was based on the qualitative responses from the
people with chronic illness who were interviewed. Few of
them participated in political activities or local govern-
ment affairs; but they did participate in clubs, religious
groups and other organizations.
In all, 207 of the 240 patients also rated the importance of
the 15 items on the original Flanagan QOLS. Table 2 sum-
marizes the findings by total group and gender. More than
50% of the patients rated all items except civic activities as
important or very important to their quality of life. Men
and women differed on four items with men rating rela-
tionships with parents, siblings and other relatives, rela-
tionships with friends, helping and encouraging others,
and socializing as significantly less important to their
quality of life.
Convergent and discriminant construct validity of the
QOLS in chronic illness groups was evidenced first by the
high correlations between the QOLS total score and the
Life Satisfaction Index-Z (LSI-Z) [18] (r = 0.67 to 0.75)
and its low to moderate correlations with the Duke-UNC
Health Profile (DUHP) [19] physical health status sub-
scale (r = 0.25 to 0.48) and a disease impact measure, the
Arthritis Impact Measurement Scales (AIMS) [20] (r =
Table 2: Importance of the QOLS items by total sample and gender. Percent rating the item as important or very important (In 
parentheses, the percent rating the item as unimportant).
Item Total Sample Men Women
1. Material well-being/financial security 83 (1) 81 (3) 83 (1)
2. Health 95 (0) 99 (0) 94 (0)
3. Relationship with parents, siblings and other relatives 80 (5) 71 (7) 85 (4)***
4. Having and raising children 79 (11) 71 (12) 81 (11)
5. Relationships with spouse or significant other 96 (3) 94 (3) 96 (3)
6. Relationships with friends 80 (3) 71 (6) 85 (1)**
7. Helping or encouraging others 86 (3) 80 (8) 91 (1)*
8. Participating in organizations and public affairs 34 (34) 33 (40) 35 (31)
9. Intellectual development 62 (20) 62 (24) 63 (18)
10. Personal understanding of self 83 (5) 84 (4) 83 (5)
11. Occupational role 84 (5) 84 (4) 83 (4)
12. Creativity/personal expression 67 (10) 61 (11) 71 (10)
13. Socializing 53 (16) 34 (22) 58 (13)*
14. Passive and observational recreation 81 (5) 79 (3) 82 (6)
15. Active and participatory recreation 51 (23) 52 (21) 50 (25)
* p < 0.05 ** p < 0.01 *** p < 0.001Page 3 of 7
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offered evidence that the QOLS could discriminate levels
of QOL in populations that would be expected to differ. A
group of healthy adults as well as groups with more stable
chronic illnesses, such as post-ostomy surgery, osteoar-
thritis, and rheumatoid arthritis, were shown to have sig-
nificantly higher scores than groups of patients with the
persistent painful condition, fibromyalgia, life-threaten-
ing COPD, or insulin-dependent diabetes [21].
More recently, a sample of 1241 chronically ill and
healthy adults from American and Swedish databases was
used to generate factor analyses for both the 15-item orig-
inal QOLS and the 16-item chronic illness adaptation.
Analysis of the data suggested that the QOLS has three fac-
tors in the healthy sample and across chronic conditions,
two languages and gender. Factors that could be labeled
(1) Relationships and Material Well-Being, (2) Health
and Functioning, and (3) Personal, Social and Commu-
nity Commitment were identified [22].
In which populations has the QOLS been used?
The QOLS has been used in studies of healthy adults and
patients with rheumatic diseases, fibromyalgia, chronic
obstructive pulmonary disease, gastrointestinal disorders,
cardiac disease, spinal cord injury, psoriasis, urinary stress
incontinence, posttraumatic stress disorder, and diabetes.
Although some researchers have questioned whether the
instrument is appropriate for children, to our knowledge
it has not been used and is probably not appropriate. It
has, however, been used to measure the quality of life of
young adults (mean age = 21 years) with juvenile rheuma-
toid arthritis [23–25].
Which translations are available?
The QOLS was originally developed and validated for
English-speaking populations in the United States. It has
been translated into at least 16 different languages: Arabic,
Danish, Farsi, French, German, Greek, Hebrew, Icelandic,
Italian, Mandarin Chinese, Norwegian, Portuguese (Por-
tugal and Brazil), Spanish (Spain and Mexico), Swedish,
Thai and Turkish.
Validated and published translations of the 16-item
QOLS exist in Swedish, Norwegian and Hebrew [15–17].
A validated version in Mandarin Chinese exists in thesis
format [26]. These translations used standardized meth-
ods of translation, backtranslation, pilot testing and cri-
tique by patients who were the intended subjects of the
questionnaire.
In all the English language work, the 7-point "delighted-
terrible" scaling format referenced above was used. In
studies using a translated version of the instrument, a 7-
point satisfaction scale anchored by "very satisfied" and
"very dissatisfied" was used because the words "delighted"
and "terrible" could not be meaningfully translated into
the other languages. As shown in Table 3, when the means
and standard deviations of the QOLS items between the
English language original and the three translated ver-
sions were compared, the 7-point satisfaction scale
appears to have as much variance as the "delighted-terri-
ble" scale.
Table 3: A comparison of the means and standard deviations of the scale items in the original English language version using the 7-point 




[15] N = 100
Norwegian
[17] N = 282
Hebrew
[16] N = 100
1. Material and physical well-being 5.6 (1.0) 5.7 (1.4) 5.5 (1.3) 4.3 (1.8)
2. Health 3.9 (1.4) 3.9 (1.6) 4.4 (1.5) 2.3 (1.5)
3. Relationships with parents, siblings and other relatives 5.3 (1.1) 6.0 (1.0) 5.5 (1.5) 5.9 (1.2)
4. Having and raising children 5.6 (1.2) 5.6 (1.6) 5.7 (1.2) 5.9 (1.2)
5. Relationship with spouse or significant other 5.5 (1.4) 5.6 (1.6) 5.5 (1.6) 5.8 (1.2)
6. Relationships with friends 5.4 (1.1) 6.2 (0.9) 5.9 (1.1) 5.4 (1.6)
7. Helping and encouraging others 5.4 (0.9) 5.3 (1.2) 5.2 (1.2) 3.0 (2.0)
8. Participating in organizations and public affairs 4.6 (1.2) 4.9 (1.6) 4.3 (1.6) 2.3 (1.9)
9. Intellectual development 4.7 (1.2) 5.2 (1.4) 4.6 (1.5) 2.1 (1.6)
10. Understanding of self 5.1 (1.1) 5.5 (1.2) 5.3 (1.1) 3.0 (1.8)
11. Occupational role 4.7 (1.4) 5.0 (1.5) 5.3 (1.4) 3.2 (1.8)
12. Creativity/personal expression 4.8 (1.2) 5.0 (1.4) 4.7 (1.6) 2.5 (1.7)
13. Socializing 4.7 (1.2) 5.3 (1.3) 5.1 (1.4) 3.6 (1.9)
14. Passive and observational recreation 5.5 (0.9) 6.0 (1.0) 5.7 (1.1) 3.6 (2.0)
15. Active and participatory recreation 4.0 (1.5) 4.0 (1.7) 4.5 (1.6) 2.2 (1.5)
16. Independence, doing for yourself* 5.0 (1.5) 5.0 (1.7) 5.2 (1.4) 3.8 (1.7)
*Note: n for this item is 146 in the English language sample.Page 4 of 7
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Over the past 20 years, a number of researchers have used
the QOLS to gather quantitative QOL information from
diverse groups of people with chronic illnesses. These ill-
nesses include diabetes mellitus [13], osteoarthritis
[13,27], gastrointestinal disorders [13,28], rheumatoid
arthritis and systemic lupus erythematosus [13,15,29–
33], chronic obstructive pulmonary disease (COPD) [14],
fibromyalgia [14,21,33–36], psoriasis [38], heart disease
[39,40], spinal cord injury [25], stress incontinence [41],
posttraumatic stress disorder [42], and low back pain
[43]. Some researchers have also found it useful for meas-
uring the QOL of parents of children with juvenile rheu-
matoid arthritis [44,45] and relatives of patients with
fibromyalgia [35].
How is the QOLS administered and how long 
does it take to complete?
The QOLS is usually self-administered either by complet-
ing the questionnaire in a clinic setting or by mail. It can
also be completed by interview format. If the interview
format is chosen, patients should be given a copy of the 7-
point response scale to refer to when making their deci-
sion as to the most appropriate point on the scale. The
QOLS can be completed in about 5 minutes.
How is the QOLS scored?
The QOLS is scored by adding up the score on each item
to yield a total score for the instrument. Scores can range
from 16 to 112. There is no automated administration or
scoring software for the QOLS.
How are the QOLS' scores interpreted?
The QOLS scores are summed so that a higher score indi-
cates higher quality of life. Average total score for healthy
populations is about 90. For rheumatic disease groups,
the average score ranges are 83 for rheumatoid arthritis,
84 for systemic lupus erythematosus, 87 for osteoarthritis,
and 92 for young adults with juvenile rheumatoid arthri-
tis. Average total scores for other conditions range from 61
for Israeli patients with posttraumatic stress disorder, to
70 for fibromyalgia, to 82 for psoriasis, urinary inconti-
nence and chronic obstructive pulmonary disease. All of
these means come from descriptive studies or experimen-
tal pretest data. And like many QOL instruments, the
means tend to be quite negatively skewed with most
patients reporting some degree of satisfaction with most
domains of their lives.
Is the QOLS responsive to change and what is a 
meaningful change for the QOLS?
There is preliminary evidence that the QOLS is reponsive
to change as a result of specific treatments. Five studies,
recently reviewed, yielded effect sizes (mean of the treated
group minus the mean of the control group divided by the
pooled standard deviation) ranging from .16 to .51 when
treated groups were compared to control groups and the
effects of differences at pretest were accounted for [41,46–
49]. The mean effect size was .24 which Cohen would call
a small effect [50]. A 6-month fibromyalgia treatment pro-
gram study with a comparison group who did not partici-
pate in the program showed an effect size for the treated
group of .41, which Cohen would classify as moderate, for
the QOLS after 6 months of multidisciplinary treatment
[51]. At 2 years, the effect size for the treated group was .48
while the non-treated group showed no change in their
QOLS scores.
Further data analysis of the above study [51] has shown
that the average patient who completed the program rated
their symptoms as 60% better than on entry. Scores
ranged from 25% worse to 100% better. When these
scores were condensed into three groups: -25% to 25%,
30% to 65% and 70% to 100%, mean total scores on the
QOLS were 67.8 (CI 61.1 to -74.6), 79.1 (CI 75.4 to 82.8)
and 82.1 (CI 77.5–86.5). QOLS mean change scores for
the three groups were -1.1 (CI -6.4 to 4.1), 8.1 (CI 4.3 to
11.9) and 7.1 (CI 3.9 to 10.3) respectively. Thus, it is rea-
sonable to expect that patients who participate in a treat-
ment program and rate their symptoms as improved by
60% or more will gain 7 to 8 points on the QOLS total
score. However, it should be noted that this applies to
group means only, as the QOLS has not been used for
individual patient assessment.
Who may I contact by e-mail to obtain a copy of 
the QOLS?
The QOLS is copyrighted by Carol Burckhardt. However,
it is considered to be in the public domain. You may con-
tact Carol Burckhardt at burckhac@ohsu.edu for a free
copy of the English language version which you may
duplicate and use in research or clinical practice. We ask
that you cite relevant QOLS articles if you publish find-
ings from studies. Alternatively, you may download a
copy of the English language version or obtain contact
information for the Swedish, Norwegian and Hebrew
translations from the MAPI site http://www.qolid.org if
you are a member.
Conclusions
The QOLS is a reliable and valid instrument for measuring
quality of life from the perspective of the patient. It
focuses on domains that come from the qualitative
descriptions of a wide range of adults across gender, cul-
tural and language groups. Although Flanagan speculated
that people with chronic illnesses might have different
quality of life priorities or concerns, no evidence of that
has ever been uncovered. Thus, the scale can be used with
confidence in chronic illness groups.Page 5 of 7
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